HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.
ICC 2019

Zhenghuan Fang

Zhenghuan Fang, Speaker at Cancer Conferences
Zhenghuan Fang
Inha University, Korea, Republic of


PhD. Fang studied drug development at the Inha University, South Korea and got PhD in 2017. And he joined the research group of Prof. Hong at the department of new drug development, Inha University. Recently, we are focusing on developing novel therapeutic strategies including tumor microenvironment and precision medicine, phytochemical agents, receptor tyrosine kinase (RTK) inhibitors, and antibody for treating various malignancies.